Literature DB >> 16327435

Separate cavity margin sampling at the time of initial breast lumpectomy significantly reduces the need for reexcisions.

Dengfeng Cao1, Clarence Lin, Seung-Hyun Woo, Russell Vang, Theodore N Tsangaris, Pedram Argani.   

Abstract

In breast conservation therapy, the margin status of the specimen predicts local recurrence and determines the need for reexcision. Many surgeons now take, at the time of lumpectomy, multiple separate "cavity margins" (CM) (the entire wall of the residual cavity) as final margins that supersede the oriented lumpectomy margins (LMs). We studied the efficacy of this method in 126 patients (23 with ductal carcinoma in situ [DCIS] only and 103 with invasive carcinoma with or without DCIS) who had an oriented lumpectomy specimen and also had four to six additional CMs. The tumors were evaluated for the following: size, grade, LM status (distance of tumor from margin and, if involved, extent of involvement), vascular invasion, lymph node status, and presence or absence of extensive intraductal component. The additional CM specimens were evaluated for residual carcinoma (if any) and its distance from the inked true margins, and the results were correlated with the corresponding LMs. Only approximately 50% of patients (52 of 103) with histologically positive LMs (defined as carcinoma within 2 mm of the inked surface) had residual carcinoma in their CMs. Additional CM sampling rendered the overall final margin status histologically negative in 61 of 103 (59%) cases with histologically positive LMs, therefore significantly reducing the need for reexcision. Younger patient age, higher number of positive LMs, high tumor grade, and the presence of extensive intraductal component were predictive of residual carcinoma in CM specimens, whereas the distance of carcinoma from the inked surface and the extent of tumor involvement of histologically positive LMs were not. Because CM specimens taken from patients with histologically positive LMs usually lack tumor, we suspect that many positive LMs are likely false positives. Possible factors accounting for false-positive LMs include seepage of ink into crevices of the specimen promoted by excessive inking, tumor friability promoting displacement of tumor into ink, manipulation of specimens for radiographs, and retraction artifact.

Entities:  

Mesh:

Year:  2005        PMID: 16327435     DOI: 10.1097/01.pas.0000180448.08203.70

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  24 in total

1.  Histopathological features of invasion of breast invasive ductal carcinoma and safety of breast-conserving surgery.

Authors:  Chunping Liu; Huaxiong Pan; Zhi Li; Lan Shi; Tao Huang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2009-02-18

2.  X-ray phase-contrast imaging of the breast--advances towards clinical implementation.

Authors:  S D Auweter; J Herzen; M Willner; S Grandl; K Scherer; F Bamberg; M F Reiser; F Pfeiffer; K Hellerhoff
Journal:  Br J Radiol       Date:  2014-02       Impact factor: 3.039

3.  Borderline atypical ductal hyperplasia/low-grade ductal carcinoma in situ on breast needle core biopsy should be managed conservatively.

Authors:  Christopher J Vandenbussche; Nagi Khouri; Eman Sbaity; Theodore N Tsangaris; Russell Vang; Armanda Tatsas; Ashley Cimino-Mathews; Pedram Argani
Journal:  Am J Surg Pathol       Date:  2013-06       Impact factor: 6.394

4.  Efficacy of intraoperative entire-circumferential frozen section analysis of lumpectomy margins during breast-conserving surgery for breast cancer.

Authors:  Tomofumi Osako; Reiki Nishimura; Yasuyuki Nishiyama; Yasuhiro Okumura; Rumiko Tashima; Masahiro Nakano; Mamiko Fujisue; Yasuo Toyozumi; Nobuyuki Arima
Journal:  Int J Clin Oncol       Date:  2015-04-09       Impact factor: 3.402

5.  The effect of simultaneous peripheral excision in breast conservation upon margin status.

Authors:  Roshani R Patel; Tianyu Li; Eric A Ross; Linda Sesa; Elin R Sigurdson; Richard J Bleicher
Journal:  Ann Surg Oncol       Date:  2010-06-12       Impact factor: 5.344

6.  Impact of margin assessment method on positive margin rate and total volume excised.

Authors:  Tracy-Ann Moo; Lydia Choi; Candice Culpepper; Cristina Olcese; Alexandra Heerdt; Lisa Sclafani; Tari A King; Anne S Reiner; Sujata Patil; Edi Brogi; Monica Morrow; Kimberly J Van Zee
Journal:  Ann Surg Oncol       Date:  2013-09-18       Impact factor: 5.344

7.  Economic Impact of Routine Cavity Margins Versus Standard Partial Mastectomy in Breast Cancer Patients: Results of a Randomized Controlled Trial.

Authors:  Anees B Chagpar; Nina R Horowitz; Brigid K Killelea; Theodore Tsangaris; Peter Longley; Sonia Grizzle; Michael Loftus; Fangyong Li; Meghan Butler; Karen Stavris; Xiaopan Yao; Malini Harigopal; Veerle Bossuyt; Donald R Lannin; Lajos Pusztai; Amy J Davidoff; Cary P Gross
Journal:  Ann Surg       Date:  2017-01       Impact factor: 12.969

8.  Scatter spectroscopic imaging distinguishes between breast pathologies in tissues relevant to surgical margin assessment.

Authors:  Ashley M Laughney; Venkataramanan Krishnaswamy; Elizabeth J Rizzo; Mary C Schwab; Richard J Barth; Brian W Pogue; Keith D Paulsen; Wendy A Wells
Journal:  Clin Cancer Res       Date:  2012-08-20       Impact factor: 12.531

9.  High and intermediate grade ductal carcinoma in-situ of the breast: a comparison of pathologic features in core biopsies and excisions and an evaluation of core biopsy features that may predict a close or positive margin in the excision.

Authors:  Oluwole Fadare; Nathan F Clement; Mohiedean Ghofrani
Journal:  Diagn Pathol       Date:  2009-08-19       Impact factor: 2.644

Review 10.  Obtaining adequate surgical margins in breast-conserving therapy for patients with early-stage breast cancer: current modalities and future directions.

Authors:  Rick G Pleijhuis; Maurits Graafland; Jakob de Vries; Joost Bart; Johannes S de Jong; Gooitzen M van Dam
Journal:  Ann Surg Oncol       Date:  2009-07-17       Impact factor: 5.344

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.